Ethyl 4-tert-butyl-1,3-thiazole-2-carboxylate, 95+%, 100mg

TERT-BUTYL 4-(4-CHLOROPHENYL)-2-OXO-2,5-DIHYDRO-1H-PYRROLE-1-CARBOXYLATE, 95.0%, 250mg

m-Cymene>99.0%(GC)0.1mL

2-(5-Amino-3-methyl-1H-pyrazol-1-yl)-6-methylpyrimidin-4(3H)-one, 95.0%, 1g

4,4-DIMETHYL-2-IMIDAZOLIDINETHIONE, 95.0%, 10g

2-Thioxo-1,2-dihydropyridine-3-carboxamide, 98%, 250mg

8-ethyl-4-(pyridine-3-carbonyl)-1-oxa-4,8-diazaspiro[4.5]decane-3-carboxylic acid, 95.0%, 1g

tert-Butyl N-(4-(4-(dimethylamino)piperidine-1-yl)-2-methoxy-5-(prop-2-enamido)phenyl)carbamate, 97%, 100mg

BENZYL 4-BENZYLMORPHOLINE-3-CARBOXYLATE, 95.0%, 1g

4-(((2-Ethylhexyl)oxy)carbonyl)benzoic acid, 97.0%, 1g

ICP multi-element standard solution CR-16, ROTI®Star, 250 ml, HDPE

8-Bromo-2-chloroimidazo[1,2-a]pyridine, 98%, 1g

2-Imidazol-1-yl-ethylamine, 95.0%, 5g